RNA Targeting

Scientists at the Hebrew University of Jerusalem have developed a new drug molecule that specifically destroys TERRA, an RNA essential for some cancer cells' survival. Using a technique called RIBOTAC, the drug identifies and breaks down this RNA without harming healthy cells. Tests in cancer cell lines showed reduced growth, suggesting potential for novel therapies.